Cleared Traditional

K240509 - STAR Apollo Mapping System

K240509 is an FDA 510(k) clearance for STAR Apollo Mapping System, manufactured by Rhythm AI, Ltd.. The device is a Class 2 Cardiovascular device with product code DQK cleared through the Traditional 510(k) pathway after a 155-day FDA review.

K240509 · Rhythm AI, Ltd. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2024
Decision
155d
Days
Class 2
Risk

K240509 is an FDA 510(k) clearance for the STAR Apollo™ Mapping System. Classified as Computer, Diagnostic, Programmable (product code DQK), Class II - Special Controls.

Submitted by Rhythm AI, Ltd. (London, GB). The FDA issued a Cleared decision on July 26, 2024 after a review of 155 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1425 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Rhythm AI, Ltd. devices

FDA 510(k) Submission Details - K240509

510(k) Number K240509 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 22, 2024
Decision Date July 26, 2024
Days to Decision 155 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
30d slower than avg
Panel avg: 125d · This submission: 155d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DQK Device Classification - Class 2, Special Controls

Product Code DQK Computer, Diagnostic, Programmable
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1425
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQK Computer, Diagnostic, Programmable

All 268
Devices cleared under the same product code (DQK) and FDA review panel - the closest regulatory comparables to K240509.
RHYTHMIA HDx™ Mapping System
K241227 · Boston Scientific Corporation · Aug 2024
HeartKey® Rhythm
K233755 · B-Secur Limited · Aug 2024
EnSite™ X EP System
K242016 · Abbott Medical · Aug 2024
Intra-Operative Positioning System (IOPS®) Viewpoint (Simple Curve Catheters)
K241243 · Centerline Biomedical, Inc. · Jul 2024
Merge Hemo, Model RCSV2
K233326 · Merge Healthcare Incorporated · Jun 2024
LumiGuide Wire
K233853 · Philips Medical Systems Nederland B.V. · Mar 2024